Meda Pharmaceuticals clinical trials
Acquired by Viatris Inc., Nov 16, 2020 · source ↗
The registry lists 19 studies whose lead sponsor is Meda Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 29, 2015.
Before and after it joined Viatris Inc.
- First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- 19
- First submitted after Meda Pharmaceuticals became part of Viatris Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Meda Pharmaceuticals19 studies
Something wrong with this grouping? Tell us on the Viatris Inc. page.
Studies
Recruiting first, then most recently updated. Showing 19 of 19. All Viatris Inc. studies →
- Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With ARCompletedNCT01880840Phase 4
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)CompletedNCT01915823Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic RhinitisCompletedNCT00720382Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00660829Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic RhinitisCompletedNCT01794741Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years OldCompletedNCT01574612Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00883168Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower BackCompletedNCT00671879Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00651118Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00740792Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00660517Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic RhinitisCompletedNCT01018862Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower BackCompletedNCT00671502Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT01368445Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial AllergiesCompletedNCT00712920Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal AllergiesCompletedNCT00720278Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00824473Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00719862Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.
- Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic RhinitisCompletedNCT00783432Phase 3
Sponsor listed in the registry: Meda Pharmaceuticals · First submitted before Meda Pharmaceuticals became part of Viatris Inc.